Table 4: Phase III - Wedge prescription: Variables for each prosthetic user with T2out of Control condidion range (extracted from Table 3 - column 2); Individual PC scores for variables that could be influenced by wedges (columns 3 to 7); Wedges positively influencing PC scores in CON (see Phase I results – Table 2).
|
variables out of CON range |
Individual score in PCs (Phase II) |
possible wedges per variable (Phase I) |
Prosthetic users |
(T2>95% CI) |
GRFvt |
GRFvt |
GRFml |
COPx |
COPx |
GRFvt |
GRFml |
COPx |
PC2 |
PC3 |
PC1 |
PC1 |
PC2 |
|
|
|
1 |
GRFvt |
0.08 |
0.03 |
n.a. |
n.a. |
n.a. |
1L |
n.w. |
n.w. |
2 |
GRFvt, GRFml |
-1.1 |
-1.98 |
3.6 |
n.a. |
n.a. |
1L, 2L, 1M,2M |
1L, 1P,2P |
n.w. |
3 |
GRFvt, GRFml, COPx |
0.3 |
-0.85 |
4.43 |
-8.02 |
-3.44 |
1L, 2L, 1M,2M |
1L, 1P, 2P |
1L |
4 |
GRFvt, GRFml, COPx |
0.78 |
-0.15 |
-0.47 |
-2 |
-1.82 |
1L, 2L, 1M,2M |
n.w. |
1L |
5 |
Ø |
n.a. |
n.a. |
n.a. |
n.a. |
n.a. |
n.w. |
n.w. |
n.w. |
6 |
GRFvt, GRFml |
0.21 |
2.44 |
0.43 |
n.a. |
n.a. |
1L |
1L, 1P, 2P |
n.w. |
7 |
GRFvt, GRFml |
0.74 |
-0.47 |
0.42 |
n.a. |
n.a. |
2L,1M |
1L, 1P, 2P |
n.w. |
8 |
GRFvt, GRFml, COPx |
-0.11 |
-0.16 |
-1.63 |
-7.38 |
2.05 |
1L, 2L, 1M,2M |
n.w. |
n.w. |
9 |
GRFvt, COPx |
0.37 |
-0.2 |
n.a. |
-0.44 |
-0.34 |
1L, 2L, 1M, 2M |
n.w. |
1L |
10 |
COPx |
n.a. |
n.a. |
n.a. |
0.3 |
-3.61 |
n.w. |
n.w. |
1L, 1M, 2M, 1P |
11 |
Ø |
n.a. |
n.a. |
n.a. |
n.a. |
n.a. |
n.w. |
n.w. |
n.w. |
12 |
Ø |
n.a. |
n.a. |
n.a. |
n.a. |
n.a. |
n.w. |
n.w. |
n.w. |
*GRFvt, GRFml, GRFap: vertical, medial-lateral and antero-posterior ground reaction forces; COPx and COPy: Center of pressure displacement.